$Safe & Green (SGBX.US)$ If you think this stock is rubbish, then sell and fck out
No need to comment here.
If you can’t handle the risk and panic easily, just sell and leave.
No need to comment here.
If you can’t handle the risk and panic easily, just sell and leave.
$New Fortress Energy (NFE.US)$
Share on X
Share on Reddit
Share on Facebook
12/04/2025 - 04:30 PM
NEW YORK--(BUSINESS WIRE)-- New Fortress Energy Inc. (NASDAQ: NFE) (the “Company”) today received final approval for a 7-year Gas Supply Agreement from the Financial Oversight and Management Board for Puerto Rico. The contract secures the delivery of approximately 75 TBtu of natural gas to support the island’s ongoing energy transformation initiatives.
Under the terms of the agreement, NFE will su...
Share on X
Share on Reddit
Share on Facebook
12/04/2025 - 04:30 PM
NEW YORK--(BUSINESS WIRE)-- New Fortress Energy Inc. (NASDAQ: NFE) (the “Company”) today received final approval for a 7-year Gas Supply Agreement from the Financial Oversight and Management Board for Puerto Rico. The contract secures the delivery of approximately 75 TBtu of natural gas to support the island’s ongoing energy transformation initiatives.
Under the terms of the agreement, NFE will su...
2
1
$Safe & Green (SGBX.US)$ good news is coming wait and see 🤓
7
$Safe & Green (SGBX.US)$ good new is coming on the way 🤓 Wait
2
2
$Clearmind Medicine (CMND.US)$ what happen ?? after good news why the price going down?
2
$Clearmind Medicine (CMND.US)$
Clearmind Medicine Inc.
Vancouver, Canada, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced that it has received final approval from the Hadassah Medical Center, Jerusalem, Israel, for its ongoing Phase 1/2a clinical trial eva...
Clearmind Medicine Inc.
Vancouver, Canada, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced that it has received final approval from the Hadassah Medical Center, Jerusalem, Israel, for its ongoing Phase 1/2a clinical trial eva...
![[empty]](https://static.moomoo.com/node_futunn_nnq/assets/images/folder.5c37692712.png)
![[error]](https://static.moomoo.com/node_futunn_nnq/assets/images/no-network.991ae8055c.png)